Join the UsAgainstAlzheimer's Membership Program

Become a Member of UsAgainstAlzheimer's today and join a movement of people who don’t just talk about the Alzheimer’s crisis, but become part of the solution.

FDA Advisory Committee Unanimously Endorses Donanemab for Full Approval

An advisory committee convened by the Food and Drug Administration (FDA) to evaluate Donanemab unanimously endorsed the drug for full FDA approval on Monday. Donanemab is a disease modifying drug that slows the progression of Alzheimer’s disease by targeting amyloid plaque in the brain. George Vradenburg, chair and co-founder of UsAgainstAlzheimer’s, issued the following statement in response to this positive development.

More Evidence that “What’s Good for the Heart is Even Better for The Brain” in early-stage Alzheimer’s patients

New study demonstrates how diet, exercise, and other interventions improved brain cognition and function after just 20 weeks

2024 Brain Health Academy

UsAgainstAlzheimer’s is bringing back its Brain Health Academy in May 2024. First launched in 2022, the Academy offers a free, comprehensive virtual program designed to equip healthcare providers and wellness professionals with the necessary tools and resources to reduce the risks associated with Alzheimer’s and related dementias. In collaboration with the American Society on Aging, participants will receive free continuing education credits to enhance their professional development and growth. Learn more about how you can access this resource today.

Listen to the BrainStorm Podcast

Featuring conversations with healthcare providers, researchers, authors, experts, caregivers, and more, BrainStorm is breaking through the silence of Alzheimer's disease. Tune in on the first and third Tuesdays of every month for a new episode, with our host, Meryl Comer.

Vivian Vasallo Appointed Vice President for Early Detection

UsAgainstAlzheimer’s is pleased to announce the appointment of Vivian Vasallo as Vice President of Early Detection. In this role, Vasallo will lead and manage the efforts at UsAgainstAlzheimer’s to identify Alzheimer’s disease in its earliest stages.

Become a Member

FDA Advisory Committee Endorses Donanemab

"What’s Good for the Heart is Even Better for The Brain”

2024 Brain Health Academy

Listen to the BrainStorm Podcast

New Vice President for Early Detection

UsAgainstAlzheimer’s is engaged in a relentless pursuit to end Alzheimer’s, the sixth leading killer in America. Our work centers on prevention, early detection and diagnosis, and access to treatments – all regardless of gender, race, or ethnicity. To achieve our mission, we give voice to patients and caregivers while partnering with government, scientists, the private sector, and allied organizations -- the people who put the “Us” in UsAgainstAlzheimer’s.


Alzheimer’s is not a normal part of aging. There are things we can all do to reduce our risk, like eating a healthy diet, exercising, and getting good sleep. People need to know what’s good for the body is good for the brain. Learn more about our prevention work and how you can take charge of your brain health.


Early Detection & Diagnosis

Early detection and diagnosis give people a better chance of managing the disease. On top of that, current treatments are most effective with patients in the early stages of dementia.

Find out how we are raising awareness of the importance of early detection and how BrainGuide is helping people concerned about their brain health start a conversation with their doctor.


Access to Treatments

We are working on multiple fronts to get safe and effective treatments into the hands of people who need them most. That includes working to ensure Alzheimer’s patients are treated fairly as the federal government considers drug approval and Medicare coverage for treatments.

See how else UsAgainstAlzheimer’s is fighting for access to treatments.



Center for Brain Health Equity

Most Alzheimer’s patients are women, Latinos, and Black people. As a patient-centered organization, all our work is done with equity in mind, so we are addressing needs of the people who are most heavily impacted by the disease. Learn more about how UsAgainstAlzheimer’s Center for Brain Health Equity is working toward a healthcare system that works for everyone.

Recent News and Blog Posts

  • June 23, 2022

    Read Full Article

    Caregiver appraisals of lucid episodes in people with late-stage Alzheimer's disease or related dementias

    Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, June 2022

    Read more
  • June 17, 2022

    UsAgainstAlzheimer’s Board Member Testifies on Alzheimer’s-Related Psychosis Before FDA Advisory Committee

    Washington, DC (June 17, 2022)— Today, UsAgainstAlzheimer’s Board Member Meryl Comer...

    Read more
  • June 17, 2022

    UsAgainstAlzheimer’s Statement on Crenezumab Trial Results

    Washington, DC (June 16, 2022) — Today, UsAgainstAlzheimer’s Chair and co-founder George...

    Read more
  • June 09, 2022

    UsAgainstAlzheimer’s Center for Brain Health Equity Launches Brain Health Equity Nurse Fellowship

    Washington, DC (June 9, 2022)— Today, UsAgainstAlzheimer’s Center for Brain Health...

    Read more
  • May 26, 2022

    UsAgainstAlzheimer’s Launches Brain Health Academy

    Washington, DC (May 26, 2022)— Today UsAgainstAlzheimer’s announced the launch of...

    Read more
  • UsAgainstAlzheimer's

    A-LIST Pulse of the Community Vol 11, May 2022

    The mission of the A-LIST is to use survey results to make...
    Read more


  • Resources

    2022 Annual Report

  • Resources
    alist 2023

    A-LIST Pulse of the Community – July 2023

  • Resources

    A-LIST Pulse of the Community – November 2022